Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice (Q42712462)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 March 2013

Language	Label	Description	Also known as
English	Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice	scientific article published on 13 March 2013

Statements

scholarly article

1 reference

Europe PubMed Central

5 November 2017

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1016/j.toxlet.2020.11.022

Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice (English)

1 reference

Europe PubMed Central

5 November 2017

object named as

Averrhoa carambola

1 reference

based on heuristic

inferred from title

object named as

Oxalidaceae

1 reference

based on heuristic

inferred from title

author name string

Ni Zheng

1

1 reference

Europe PubMed Central

5 November 2017

Xing Lin

2

1 reference

Europe PubMed Central

5 November 2017

Qingwei Wen

3

1 reference

Europe PubMed Central

5 November 2017

Kintoko

4

1 reference

Europe PubMed Central

5 November 2017

Shijun Zhang

5

1 reference

Europe PubMed Central

5 November 2017

Jianchun Huang

6

1 reference

Europe PubMed Central

5 November 2017

Xiaohui Xu

7

1 reference

Europe PubMed Central

5 November 2017

Renbin Huang

8

1 reference

Europe PubMed Central

5 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 March 2013

1 reference

Europe PubMed Central

5 November 2017

Toxicology Letters

1 reference

Europe PubMed Central

5 November 2017

219

1 reference

Europe PubMed Central

5 November 2017

1

1 reference

Europe PubMed Central

5 November 2017

77-84

1 reference

Europe PubMed Central

5 November 2017

Convulsant activity and neurochemical alterations induced by a fraction obtained from fruit Averrhoa carambola (Oxalidaceae: Geraniales).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Advanced glycation end-products and the kidney

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Diabetic nephropathy: where hemodynamics meets metabolism

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Diabetic nephropathy: mechanisms of renal disease progression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The benefits of tight glycemic control in type 2 diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Phenolic and lignan glycosides from the butanol extract of Averrhoa carambola L. root

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Oxidative stress and diabetic complications

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Pathogenesis of diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The effect of verapamil on the antioxidant defence system in diabetic kidney.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Regulation of obese gene expression in KK mice and congenic lethal yellow obese KKAy mice.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Some thoughts on the future of ethnopharmacology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Advanced glycation end products and diabetic nephropathy.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Transforming growth factor beta contributes to progressive diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Roots of Withania somnifera Inhibit Forestomach and Skin Carcinogenesis in Mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Structural-functional relationships in diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Progression of diabetic nephropathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.TOXLET.2013.03.001

Identifiers

10.1016/J.TOXLET.2013.03.001

1 reference

Europe PubMed Central

5 November 2017

1 reference

Europe PubMed Central

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42712462&oldid=2043194667"